AKT1 and Alzheimer disease: In particular, resveratrol (Res) also has neuroprotective properties, and in recent research, it was indicated that a small Resselenium–peptide nanocomposite improves cognitive disorder through various mechanisms, one of which is via preventing Akt from being phosphorylated in brains of AD model mice (Li C. et al., 2021).